Variable | All | Fazekas score | |||
---|---|---|---|---|---|
Patients | 0–2 | 3–6 | 0–5 | 6 | |
% patients (n) | 100% (45) | 57% (26) | 43% (20) | 93% (43) | 7% (3) |
Age (years) | |||||
 Median | 60.5 | 54.5 | 65.5 | 59.0 | 72.0 |
 Range | 35–82 | 35–74 | 46–82 | 35–82 | 70–82 |
 ≤ 65 | 71.7% | 88% | 50% | 77% | 0% |
Baseline KPS | |||||
 Median | 85 | 90 | 80 | 80 | 80 |
 70–80 | 50% | 44% | 65% | 51% | 100% |
 90–100 | 50% | 56% | 35% | 49% | 0% |
Highest educationa | |||||
 Median | 13 | 13 | 13 | 13 | 13 |
 Range | 11–13 | 11–13 | 11–13 | 11–13 | 12–13 |
Baseline MoCA | |||||
 Median | 27.5 | 27.5 | 27.5 | 28 | 26.0 |
 Range | 20–30 | 20–30 | 20–30 | 20–30 | 20–30 |
Metastases (no.) | |||||
 Median | 3 | 3.5 | 2.5 | 3 | 1 |
 Range | 1–10 | 1–10 | 1–10 | 1–10 | 1–3 |
Volume of metastases (cm3) | |||||
 Mean | 4.1 | 5.0 | 3.0 | 4.0 | 5.2 |
Peritumoral edemab (cm3) | |||||
 Mean | 38.4 | 38.1 | 38.9 | 38.4 | 39.7 |
Intracranial volume (cm3) | |||||
 Mean | 1531 | 1524 | 1542 | 1530 | 1557 |
WMH volume (cm3) | |||||
 Mean | 8.0 | 1.8 | 16.0 | 5.0 | 50.4 |